KMKim McFann

Kim McFann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kim McFann has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The effect of insurance status and parental education on glycemic control and cardiovascular disease risk profile in youth with Type 1 Diabetes

    by Shideh Majidi, R Paul Wadwa, Franziska K Bishop, Georgeanna J Klingensmith, Marian Rewers, Kim McFann, David M Maahs

    Adult studies have shown a correlation between low socioeconomic status and Type 1 Diabetes complications, but studies have not been done in children to examine the effect of socioeconomic status on risk for future complications. This study investigates the relationship between insurance status and parental education and both glycemic control and cardiovascular disease (CVD) risk factors in youth with type 1 diabetes.


  • Hemoglobin A1c assay variations and implications for diabetes screening in obese youth

    by Christine L. Chan, Kim McFann, Lindsey Newnes, Kristen J. Nadeau, Philip S. Zeitler, Megan Kelsey

    Background Standardization of the hemoglobin A1c (A1c) assay has led to its increasing utilization as a screening tool for the diagnosis of prediabetes and type 2 diabetes in youth. However, significant A1c assay variability remains and has implications for clinical management. Objective To describe our center's experiences with A1c results in youth and to evaluate inter‐method differences and their clinical implications. Subjects Seventy‐five youth (aged 10–18 yr old), body mass index (BMI) ≥85th‰ participated. Methods Seventy‐two participants had two A1c values performed on the same sample, one via immunoassay (DCA Vantage Analyzer, A1c1) and the other via high performance liquid chromatography (Bio‐Rad Variant II, A1c2). Nineteen had A1c run on two immunoassay devices (A1c1 and Dimensions Vista, A1c3). Results Mean age of participants was 13.9 years, BMI% 97.89%, 33% male, 16% white, 21% black, and 61% Hispanic (H). Mean A1c1 was 5.68% ± 0.38 vs. a mean A1c2 of 5.73% ± 0.39, p = 0.049. Concordance in diabetes status between methods was achieved in 79% of subjects. Nineteen subjects with A1c3 results had testing performed an average of 22 ± 9 days prior to A1c1. Mean A1c3 was 6.24% ± 0.4, compared to a mean A1c1 of 5.74% ± 0.31, (p < 0.0001). A1c1 was on average systematically −0.5 ± 0.28 lower compared to A1c3. There was poor agreement in diabetes classification between A1c1 and A1c3, with a concordance in classification between methods of only 36.8%. Conclusions Clinically significant inter‐method A1c variability exists that impacts patient classification and treatment recommendations. In the screening of obese youth for diabetes, A1c results should be interpreted with caution.


  • Open Access

    Lower A1c among adolescents with lower perceived A1c goal: a cross-sectional survey

    by Scott A Clements, Matthew D Anger, Franziska K Bishop, Kim K McFann, Georgeanna J Klingensmith, David M Maahs, R Paul Wadwa


  • Open Access

    Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation

    by Jeffrey C Sirota, Angela Walcher, Sarah Faubel, Alkesh Jani, Kim McFann, Prasad Devarajan, Connie L Davis, Charles L Edelstein

    Background: AKI is common following liver transplantation and is associated with significant morbidity and mortality. Biomarkers of AKI have not been well established in this setting but are needed to help guide patient care and facilitate development of novel therapeutics. Methods: Serum creatinine, cystatin C, IL-6, and IL-8 and urine IL-18, NGAL, IL-6, and IL-8 were measured before and within 24 hours after liver transplantation in 40 patients. AKI was defined as a ≥50% sustained increase in creatinine above pre-operative values occurring within 24 hours of transplantation and persisting for at least 24 hours. Results: Seven patients met criteria for AKI (17.5%), with mean creatinines of 0.81 mg/dL pre-operatively and 1.75 mg/dL post-operatively. While pre-operative biomarker levels in patients with AKI were similar to those in patients without AKI, differences were seen between the groups with regard to median post-operative serum IL-8 (pg/mL) (242.48 vs. 82.37, p = 0.0463) and urine NGAL (ng/mL) (386.86 vs. 24.31, p = 0.0039), IL-6 (pg/mL) (52 vs. 7.29, p=0.0532), IL-8 (pg/mL) (14.3 vs. 0, p = 0.0224), and IL-18 (pg/mL) (883.09 vs. 0, p = 0.0449). The areas under receiver operating characteristic (ROC) curves were 0.749 for urine IL-18, 0.833 for urine NGAL, 0.745 for urine IL-6, 0.682 for serum IL-6, 0.773 for urine IL-8, and 0.742 for serum IL-8. Post-operative cystatin C was not significantly different between AKI and no AKI groups. Conclusion: Serum IL-8 and urine IL-18, NGAL, IL-6, and IL-8 are elevated in AKI within the first 24 hours following liver transplantation.


  • Open Access

    Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes

    by Bahareh M Schweiger, Janet K Snell-Bergeon, Rossana Roman, Kim McFann, Georgeanna J Klingensmith

    Menarche delay has been reported in adolescent females with type 1 diabetes (T1DM), perhaps due to poor glycemic control. We sought to compare age at menarche between adolescent females with T1DM and national data, and to identify factors associated with delayed menarche and menstrual irregularity in T1DM.